Related Experiment Video

Updated: Jan 25, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

1.1K

Clinical papers of the year 2018 - Cystic fibrosis

I M Balfour-Lynn1

  • 1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, UK.

Paediatric Respiratory Reviews
|May 5, 2019
PubMed

Insights

This review covers key 2018 clinical research in cystic fibrosis (CF), focusing on CFTR modulator therapies, clinical trials, and infection management. It highlights advancements in treating this genetic disorder.

Area of Science:

  • Medical Research
  • Pulmonology
  • Genetics

Background:

  • Cystic Fibrosis (CF) is a multi-system genetic disorder.
  • Significant research advancements have been made in CF treatment.
  • 2018 saw critical developments in clinical management and therapeutic strategies.

Purpose of the Study:

  • To review pivotal clinical papers on cystic fibrosis published in 2018.
  • To focus on emerging CFTR modulator therapies and their clinical impact.
  • To analyze randomized controlled trials and infection/microbiology research in CF.

Main Methods:

  • Comprehensive literature search of PubMed for clinical papers published in 2018.
  • Selection of high-impact studies focusing on CFTR modulator therapy.
  • Inclusion of research on randomized controlled trials and microbial challenges in CF.

Main Results:

  • CFTR modulator therapy continues to be a major focus, with ongoing trials and emerging data.
  • Randomized controlled trials are essential for validating new therapeutic approaches.
  • Infection and microbiology remain critical areas, with new insights into pathogen management.

Conclusions:

  • 2018 was a significant year for clinical cystic fibrosis research.
  • CFTR modulator therapies show promise for improving patient outcomes.
  • Continued research in infection control and microbiology is vital for comprehensive CF care.

Keywords:
Airway microbiologyCFTR modulatorsCystic fibrosis

More Related Videos

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis07:56

Rectal Organoid Morphology Analysis ROMA: A Diagnostic Assay in Cystic Fibrosis

Published on: June 10, 2022

3.3K
Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

1.8K

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
746
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
489
Nursing Clinical Information System01:27

Nursing Clinical Information System

Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.4K